Roger Li/moffitt.org
Jul 23, 2025, 16:56
Roger Li: Results from BCG+MMC Trial in the BCG-Naive Setting
Roger Li, Urologic oncologist at Moffitt Cancer Center, shared on X:
“Dickon Hayne presenting the results from BCG+MMC trial in the BCG-naive setting
- Possible signal in higher staged patients
- High compliance
- Saves BCG in the era of shortage
Difference between monthly maintenance vs swog
Effect additive vs synergistic.”
More posts featuring ANZUP25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 9, 2025, 18:18
Sep 9, 2025, 17:59
Sep 9, 2025, 17:43
Sep 9, 2025, 16:51
Sep 9, 2025, 15:59